Clinical trial · Interventional
Transpelvic Magnetic Stimulation to Improve Urogenital Function
Feasibility Testing of Transpelvic Magnetic Stimulation as a Novel Intervention toImprove Urogenital Function in Prostate Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
After recruitment, 20 male patients will be assigned 1:1 to either age-matched control (G1: sham) or age-matched intervention (G2: pelvic magnetic stimulation; TPMS) groups using computer-generated process, and baseline parameters will be established. All patients will be instructed by the investigators to perform standard of care pelvic floor exercise for the duration of the study. In addition, G2 patients will receive TPMS, while G1 patients will undergo sham treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Erectile Dysfunction | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sham Magnetic stimulation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Magnetic Stimulation
- description
- Patients will be subjected to TPMS.
- interventionNames
- Procedure: Sham Magnetic stimulation
- type
- NO_INTERVENTION
- label
- Sham TPMS
- description
- Patients will be subjected to sham TPMS
Primary outcomes (3)
- measure
- Number of Participants Recruited
- timeFrame
- During 12-weeks therapy
- description
- Primary outcome measure will be to determine feasibility of recruitment of prostate cancer survivors. We will demonstrate recruitment in VASDHS urology clinics .
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 50 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * men over 50 years old who are enrolled for prostate surgery, * have serum testosterone within normal limits, and * are without prior bilateral orchiectomy, chemotherapy, external radiotherapy, brachytherapy, surgical, or other ablative therapy for prostate cancer. Exclusion Criteria: * patients with ED caused by psychological, neurogenic (after non-nerve sparing prostate surgery), or hormonal disorders, * patients with genital abnormalities precluding intercourse, prior penile implantation, ongoing erectile aid use, or use of nitrate medications. * Androgen suppression within the past 6 months or as part of protocol-specified radiotherapy or brachytherapy will be excluded.
References
Publications (0)
Data not yet available